Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Sonova concludes 2021-22 share buyback and will start a new three-year buyback program of up to CHF 1.5 billion
Sonova concludes 2021-22 share buyback and will start a new three-year buyback program of up to CHF 1.5 billion
Sonova concludes 2021-22 share buyback and will start a new three-year buyback program of up to CHF 1.5 billion
eqs_en 
0 29.03.22
MD Medical Group Investments Plc: MD Medical Group announces the Annual General Meeting
MD Medical Group Investments Plc: MD Medical Group announces the Annual General Meeting
MD Medical Group Investments Plc: MD Medical Group announces the Annual General Meeting
eqs_en 
0 28.03.22
MD Medical Group Investments Plc: MD Medical Group posts 37.7% EBITDA, 41.8% Net profit growth in FY 2021
MD Medical Group Investments Plc: MD Medical Group posts 37.7% EBITDA, 41.8% Net profit growth in FY 2021
MD Medical Group Investments Plc: MD Medical Group posts 37.7% EBITDA, 41.8% Net profit growth in FY 2021
eqs_en 
0 28.03.22
MD Medical Group Investments Plc: MD MEDICAL GROUP ANNUAL REPORT 2021
MD Medical Group Investments Plc: MD MEDICAL GROUP ANNUAL REPORT 2021
MD Medical Group Investments Plc: MD MEDICAL GROUP ANNUAL REPORT 2021
eqs_en 
0 28.03.22
DGAP-Adhoc: Eckert & Ziegler to Increase Dividend Proposal
DGAP-Adhoc: Eckert & Ziegler to Increase Dividend Proposal
DGAP-Adhoc: Eckert & Ziegler to Increase Dividend Proposal
eqs_en 
0 24.03.22
DGAP-Adhoc: Eckert & Ziegler erhöht Dividendenvorschlag
DGAP-Adhoc: Eckert & Ziegler erhöht Dividendenvorschlag
DGAP-Adhoc: Eckert & Ziegler erhöht Dividendenvorschlag
eqs_de 
0 24.03.22
DGAP-News: Eckert & Ziegler liefert Lutetium-177 für klinische Studien der kanadischen Alpha-9 Theranostics
DGAP-News: Eckert & Ziegler liefert Lutetium-177 für klinische Studien der kanadischen Alpha-9 Theranostics
DGAP-News: Eckert & Ziegler liefert Lutetium-177 für klinische Studien der kanadischen Alpha-9 Theranostics
eqs_de 
0 23.03.22
DGAP-News: Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials
DGAP-News: Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials
DGAP-News: Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials
eqs_en 
0 23.03.22
DGAP-News: Eckert & Ziegler erweitert Liefervertrag mit Sirtex Medical auf chinesischen Markt
DGAP-News: Eckert & Ziegler erweitert Liefervertrag mit Sirtex Medical auf chinesischen Markt
DGAP-News: Eckert & Ziegler erweitert Liefervertrag mit Sirtex Medical auf chinesischen Markt
eqs_de 
0 22.03.22
DGAP-News: Eckert & Ziegler Extends Supply Agreement with Sirtex Medical to Chinese Market
DGAP-News: Eckert & Ziegler Extends Supply Agreement with Sirtex Medical to Chinese Market
DGAP-News: Eckert & Ziegler Extends Supply Agreement with Sirtex Medical to Chinese Market
eqs_en 
0 22.03.22
DGAP-News: MicroVision's Leaders to Participate in Webcast Fireside Chat with Cantor Fitzgerald Analyst on March 22, 2022
DGAP-News: MicroVision's Leaders to Participate in Webcast Fireside Chat with Cantor Fitzgerald Analyst on March 22, 2022
DGAP-News: MicroVision's Leaders to Participate in Webcast Fireside Chat with Cantor Fitzgerald Analyst on March 22, 2022
eqs_en 
0 21.03.22
DGAP-News: Vita 34 sets course for accelerated growth in new business areas with changes in the Management Board
DGAP-News: Vita 34 sets course for accelerated growth in new business areas with changes in the Management Board
DGAP-News: Vita 34 sets course for accelerated growth in new business areas with changes in the Management Board
eqs_en 
0 18.03.22
DGAP-News: Vita 34 stellt mit Vorstandsumbau Weichen für beschleunigtes Wachstum in neuen Geschäftsfeldern
DGAP-News: Vita 34 stellt mit Vorstandsumbau Weichen für beschleunigtes Wachstum in neuen Geschäftsfeldern
DGAP-News: Vita 34 stellt mit Vorstandsumbau Weichen für beschleunigtes Wachstum in neuen Geschäftsfeldern
eqs_de 
0 18.03.22
DGAP-Adhoc: Vita 34 AG: Change in the Chair of the Management Board
DGAP-Adhoc: Vita 34 AG: Change in the Chair of the Management Board
DGAP-Adhoc: Vita 34 AG: Change in the Chair of the Management Board
eqs_en 
0 18.03.22
DGAP-Adhoc: Vita 34 AG: Wechsel im Vorstandsvorsitz
DGAP-Adhoc: Vita 34 AG: Wechsel im Vorstandsvorsitz
DGAP-Adhoc: Vita 34 AG: Wechsel im Vorstandsvorsitz
eqs_de 
0 18.03.22
MD Medical Group Investments Plc: MD Medical Group announces board of directors changes
MD Medical Group Investments Plc: MD Medical Group announces board of directors changes
MD Medical Group Investments Plc: MD Medical Group announces board of directors changes
eqs_en 
0 09.03.22
Urteil in Patentverletzungsprozess -  Advanced Bionics legt Berufung ein
Urteil in Patentverletzungsprozess -  Advanced Bionics legt Berufung ein
Urteil in Patentverletzungsprozess -  Advanced Bionics legt Berufung ein
eqs_de 
0 08.03.22
Judgment in patent infringement case - Advanced Bionics files appeal
Judgment in patent infringement case - Advanced Bionics files appeal
Judgment in patent infringement case - Advanced Bionics files appeal
eqs_en 
0 08.03.22
DGAP-News: Bio-Gate AG: Bio-Gate erreicht 2021 alle Finanzziele und stärkt Produkt- und Technologie-Pipeline
DGAP-News: Bio-Gate AG: Bio-Gate erreicht 2021 alle Finanzziele und stärkt Produkt- und Technologie-Pipeline
DGAP-News: Bio-Gate AG: Bio-Gate erreicht 2021 alle Finanzziele und stärkt Produkt- und Technologie-Pipeline
eqs_de 
0 07.03.22
MD Medical Group Investments Plc: MD Medical Group announces board of directors changes
MD Medical Group Investments Plc: MD Medical Group announces board of directors changes
MD Medical Group Investments Plc: MD Medical Group announces board of directors changes
eqs_en 
0 07.03.22
2021 financial year: Sharp rise in sales and profits
2021 financial year: Sharp rise in sales and profits
2021 financial year: Sharp rise in sales and profits
eqs_en 
0 04.03.22
Geschäftsjahr 2021: Markante Umsatz- und Gewinnsteigerung
Geschäftsjahr 2021: Markante Umsatz- und Gewinnsteigerung
Geschäftsjahr 2021: Markante Umsatz- und Gewinnsteigerung
eqs_de 
0 04.03.22
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
eqs_en 
0 02.03.22
MD Medical Group Investments Plc: MD Medical Group announces Board of Directors changes
MD Medical Group Investments Plc: MD Medical Group announces Board of Directors changes
MD Medical Group Investments Plc: MD Medical Group announces Board of Directors changes
eqs_en 
0 02.03.22
Sonova completes acquisition of the Sennheiser Consumer Division and forms a new business
Sonova completes acquisition of the Sennheiser Consumer Division and forms a new business
Sonova completes acquisition of the Sennheiser Consumer Division and forms a new business
eqs_en 
0 01.03.22